Ellen Clare Schofield

Ms. Ellen Clare Schofield

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SOSuna Onengut-Gumuscu
Suna Onengut-Gumuscu
WCWei-Min Chen
Wei-Min Chen
OBOliver Burren
Oliver Burren
NCNick J Cooper
Nick J Cooper
AQAaron R Quinlan
Aaron R Quinlan
SRStephen S Rich
Stephen S Rich
Stephen Rich and colleagues report the discovery and fine mapping of type 1 diabetes susceptibility loci using the Immunochip. They also perform comparative analyses with 15 other immune disorders and find evidence of colocalization of causal variants with lymphoid gene enhancers. Genetic studies of type 1 diabetes (T1D) have identified 50 susceptibility regions1,2, finding major pathways contributing to risk3, with some loci shared across immune disorders4,5,6. To make genetic comparisons across autoimmune disorders as informative as possible, a dense genotyping array, the Immunochip, was developed, from which we identified four new T1D-associated regions (P < 5 × 10−8). A comparative analysis with 15 immune diseases showed that T1D is more similar genetically to other autoantibody-positive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least similar to ulcerative colitis, and provided support for three additional new T1D risk loci. Using a Bayesian approach, we defined credible sets for the T1D-associated SNPs. The associated SNPs localized to enhancer sequences active in thymus, T and B cells, and CD34+ stem cells. Enhancer-promoter interactions can now be analyzed in these cell types to identify which particular genes and regulatory sequences are causal.

5 March 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
HGHui Guo
Hui Guo
MFMary D. Fortune
Mary D. Fortune
OBOliver S. Burren
Oliver S. Burren
ESEllen Clare Schofield
Ellen Clare Schofield
JTJohn A. Todd
John A. Todd
CWChris Wallace
Chris Wallace
The genes and cells that mediate genetic associations identified through genome-wide association studies (GWAS) are only partially understood. Several studies that have investigated the genetic regulation of gene expression have shown that disease-associated variants are over-represented amongst expression quantitative trait loci (eQTL) variants. Evidence for colocalisation of eQTL and disease causal variants can suggest causal genes and cells for these genetic associations. Here, we used colocalisation analysis to investigate whether 595 genetic associations to ten immune-mediated diseases are consistent with a causal variant that regulates, in cis, gene expression in resting B cells, and in resting and stimulated monocytes. Previously published candidate causal genes were over-represented amongst genes exhibiting colocalisation (odds ratio > 1.5), and we identified evidence for colocalisation (posterior odds > 5) between cis eQTLs in at least one cell type and at least one disease for six genes: ADAM15, RGS1, CARD9, LTBR, CTSH and SYNGR1. We identified cell-specific effects, such as for CTSH, the expression of which in monocytes, but not in B cells, may mediate type 1 diabetes and narcolepsy associations in the chromosome 15q25.1 region. Our results demonstrate the utility of integrating genetic studies of disease and gene expression for highlighting causal genes and cell types.

8 June 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MFMary D Fortune
Mary D Fortune
HGHui Guo
Hui Guo
OBOliver Burren
Oliver Burren
ESEllen Clare Schofield
Ellen Clare Schofield
NWNeil M Walker
Neil M Walker
CWChris Wallace
Chris Wallace
Mary Fortune, Chris Wallace and colleagues report a new method that allows statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. They apply their method to type 1 diabetes, rheumatoid arthritis, celiac disease and multiple sclerosis and highlight the complexity in genetic variation underlying these distinct autoimmune diseases. Determining whether potential causal variants for related diseases are shared can identify overlapping etiologies of multifactorial disorders. Colocalization methods disentangle shared and distinct causal variants. However, existing approaches require independent data sets. Here we extend two colocalization methods to allow for the shared-control design commonly used in comparison of genome-wide association study results across diseases. Our analysis of four autoimmune diseases—type 1 diabetes (T1D), rheumatoid arthritis, celiac disease and multiple sclerosis—identified 90 regions that were associated with at least one disease, 33 (37%) of which were associated with 2 or more disorders. Nevertheless, for 14 of these 33 shared regions, there was evidence that the causal variants differed. We identified new disease associations in 11 regions previously associated with one or more of the other 3 disorders. Four of eight T1D-specific regions contained known type 2 diabetes (T2D) candidate genes (COBL, GLIS3, RNLS and BCAR1), suggesting a shared cellular etiology.

4 September 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
OBOliver S. Burren
Oliver S. Burren
AGArcadio Rubio García
Arcadio Rubio García
Biola M. JavierreBiola M. Javierre
Biola M. Javierre
DRDaniel B. Rainbow
Daniel B. Rainbow
JCJonathan Cairns
Jonathan Cairns
CWChris Wallace
Chris Wallace
Autoimmune disease-associated variants are preferentially found in regulatory regions in immune cells, particularly CD4+ T cells. Linking such regulatory regions to gene promoters in disease-relevant cell contexts facilitates identification of candidate disease genes. Within 4 h, activation of CD4+ T cells invokes changes in histone modifications and enhancer RNA transcription that correspond to altered expression of the interacting genes identified by promoter capture Hi-C. By integrating promoter capture Hi-C data with genetic associations for five autoimmune diseases, we prioritised 245 candidate genes with a median distance from peak signal to prioritised gene of 153 kb. Just under half (108/245) prioritised genes related to activation-sensitive interactions. This included IL2RA, where allele-specific expression analyses were consistent with its interaction-mediated regulation, illustrating the utility of the approach. Our systematic experimental framework offers an alternative approach to candidate causal gene identification for variants with cell state-specific functional effects, with achievable sample sizes.

1 March 2021 in Microbial Genomics
Verified
Journal Article
Open access
CMCatriona Mitchell
Catriona Mitchell
KSKaren F. Steward
Karen F. Steward
ACAmelia R. L. Charbonneau
Amelia R. L. Charbonneau
SWSaoirse Walsh
Saoirse Walsh
HWHayley Wilson
Hayley Wilson
AWAndrew S. Waller
Andrew S. Waller
The equine disease strangles, which is characterized by the formation of abscesses in the lymph nodes of the head and neck, is one of the most frequently diagnosed infectious diseases of horses around the world. The causal agent, Streptococcus equi subspecies equi , establishes a persistent infection in approximately 10 % of animals that recover from the acute disease. Such ‘carrier’ animals appear healthy and are rarely identified during routine veterinary examinations pre-purchase or transit, but can transmit S. equi to naïve animals initiating new episodes of disease. Here, we report the analysis and visualization of phylogenomic and epidemiological data for 670 isolates of S. equi recovered from 19 different countries using a new core-genome multilocus sequence typing (cgMLST) web bioresource. Genetic relationships among all 670 S. equi isolates were determined at high resolution, revealing national and international transmission events that drive this endemic disease in horse populations throughout the world. Our data argue for the recognition of the international importance of strangles by the Office International des Épizooties to highlight the health, welfare and economic cost of this disease. The Pathogenwatch cgMLST web bioresource described herein is available for tailored genomic analysis of populations of S. equi and its close relative S. equi subspecies zooepidemicus that are recovered from horses and other animals, including humans, throughout the world. This article contains data hosted by Microreact.

28 March 2025 in Science
Verified
Journal Article
Open access
Natalie WallisNatalie Wallis
Natalie Wallis
AMAlyce McClellan
Alyce McClellan
AMAlexander Mörseburg
Alexander Mörseburg
KKKatherine A. Kentistou
Katherine A. Kentistou
AJAqfan Jamaluddin
Aqfan Jamaluddin
EREleanor Raffan
Eleanor Raffan
Obesity is a heritable disease, but its genetic basis is incompletely understood. Canine population history facilitates trait mapping. We performed a canine genome-wide association study for body condition score—a measure of obesity—in 241 Labrador retrievers. Using a cross-species approach, we showed that canine obesity genes are also associated with rare and common forms of obesity in humans. The lead canine association was within the gene DENN domain containing 1B ( DENND1B ). Each copy of the alternate allele was associated with ~7% greater body fat. We demonstrate a role for this gene in regulating signaling and trafficking of melanocortin 4 receptor, a critical controller of energy homeostasis. Thus, canine genetics identified obesity genes and mechanisms relevant to both dogs and humans.